Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma

Wang,Jun Pu; Hu,Wan Ming; Wang,Kuan Song; Luo,Bai Hua; Wu,Chang; Chen,Zhi Hong; Luo,Geng Qiu; Liu,Yu Wu; Liu,Qin Lai; Yu,Jun; Li,Jing He; Wen,Ji Fang

doi:10.3892/etm.2012.568

Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma

Authors:
- Jun Pu Wang
- Wan Ming Hu
- Kuan Song Wang
- Bai Hua Luo
- Chang Wu
- Zhi Hong Chen
- Geng Qiu Luo
- Yu Wu Liu
- Qin Lai Liu
- Jun Yu
- Jing He Li
- Ji Fang Wen
View Affiliations

Affiliations: Department of Pathology, School of Basic Medicine, Changsha, Hunan 410013, P.R. China, Third Xiang-ya Hospital, Central South University, Changsha, Hunan 410013, P.R. China
Published online on: May 7, 2012 https://doi.org/10.3892/etm.2012.568
Pages: 55-60

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chemokine receptors play multiple roles in the development and progression of various tumor types. The aim of this study was to examine C-X-C chemokine receptor type 1 (CXCR1) protein expression in gastric adenocarcinoma and to investigate the clinical implications of CXCR1 upregulation. Expression of CXCR1 protein in 83 specimens of sporadic gastric adenocarcinoma and their corresponding non-neoplastic mucosa obtained by gastrectomy was assayed using immunohistochemistry. The intensity of immunostaining in tumor tissue was considered strong when tumor tissue staining was more intense than in the corresponding non-neoplastic mucosa; the intensity was null when staining was weaker in the tumor than in the corresponding non-neoplastic mucosa; and the intensity was weak when staining was similar in both tissues. Microvascular density in tumor tissue and its corresponding non-neoplastic mucosa was measured using monoclonal antibody against CD34. A strong correlation was observed between elevated CXCR1 protein expression and tumor stage (P<0.05). T stage, N stage and overall stage positively correlated with CXCR1 protein expression. Microvascular density was higher in tumors with strong CXCR1 protein expression, but the correlation with CXCR1 was not linear (P=0.07). Multiple logistic regression analyses showed that, compared to no or weak expression, overexpression of CXCR1 protein was a significant risk factor for high N stage (N2, N3). These results indicate that CXCR1 may be considered as a new and promising target for gastric adenocarcinoma therapy.

View Figures

View References

1	Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 14(Suppl 2): 31–36. 2003. View Article : Google Scholar : PubMed/NCBI
2	Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol. 12:17–20. 2006.
3	Lu JB, Sun XB, Dai DX, et al: Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol. 9:2400–2403. 2003.PubMed/NCBI
4	Hyung WJ, Noh SH, Yoo CH, et al: Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg. 26:323–329. 2002. View Article : Google Scholar : PubMed/NCBI
5	Park JY, Park KH, Bang S, et al: CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol. 133:835–840. 2007. View Article : Google Scholar : PubMed/NCBI
6	Fidler IJ: Critical determinants of metastasis. Semin Cancer Biol. 12:89–96. 2002. View Article : Google Scholar
7	Murphy PM, Baggiolini M, Charo IF, et al: International union of pharmacology. XXII Nomenclature for chemokine receptors. Pharmacol Rev. 52:145–176. 2000.PubMed/NCBI
8	Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity. 12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
9	Rossi D and Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol. 18:217–243. 2000. View Article : Google Scholar : PubMed/NCBI
10	Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
11	Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
12	Johrer K, Zelle-Rieser C, Perathoner A, et al: Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res. 11:2459–2465. 2005. View Article : Google Scholar : PubMed/NCBI
13	Scotton CJ, Wilson JL, Milliken D, Stamp G and Balkwill FR: Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 61:4961–4965. 2001.PubMed/NCBI
14	Schimanski CC, Schwald S, Simiantonaki N, et al: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res. 11:1743–1750. 2005. View Article : Google Scholar : PubMed/NCBI
15	Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
16	Lazennec G and Richmond A: Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med. 16:133–144. 2010. View Article : Google Scholar : PubMed/NCBI
17	Charo IF and Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 354:610–621. 2006. View Article : Google Scholar : PubMed/NCBI
18	Tan MC, Goedegebuure PS, Belt BA, et al: Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol. 182:1746–1755. 2009. View Article : Google Scholar : PubMed/NCBI
19	Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and metastasis. Cancer Sci. 96:317–322. 2005. View Article : Google Scholar : PubMed/NCBI
20	Hu JY, Deng XY, Bian XW, et al: The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma. Clin Cancer Res. 11:4658–4665. 2005. View Article : Google Scholar : PubMed/NCBI
21	Waugh DJ and Wilson C: The interleukin-8 pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
22	Ginestier C, Liu S, Diebel ME, et al: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 120:485–497. 2010. View Article : Google Scholar : PubMed/NCBI
23	Singh S, Nannuru KC, Sadanandam A, Varney ML and Singh RK: CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer. 100:1638–1646. 2009. View Article : Google Scholar : PubMed/NCBI
24	Eck M, Schmausser B, Scheller K, Brandlein S and Muller-Hermelink HK: Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol. 134:508–515. 2003. View Article : Google Scholar : PubMed/NCBI
25	Kitadai Y, Takahashi Y, Haruma K, et al: Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer. 81:647–653. 1999. View Article : Google Scholar : PubMed/NCBI
26	Lin BR, Chang CC, Chen LR, et al: Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2. Mol Cancer Res. 5:1111–1123. 2007. View Article : Google Scholar : PubMed/NCBI
27	Croker AK, Goodale D, Chu J, et al: High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med. 13:2236–2252. 2009. View Article : Google Scholar : PubMed/NCBI
28	Kitadai Y, Haruma K, Mukaida N, et al: Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res. 6:2735–2740. 2000.PubMed/NCBI
29	Ju DW, Wei PK, Lin HM, Sun DZ, Yu S and Xiu LJ: Effects of Xiaotan Sanjie decoction on expressions of interleukin-8 and its receptors in gastric tumor xenografts and gastric tissue adjacent to the tumor in mice. Zhong Xi Yi Jie He Xue Bao. 8:74–79. 2010.(In Chinese).
30	Wulfing P, Kersting C, Tio J, et al: Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res. 10:2393–2400. 2004. View Article : Google Scholar : PubMed/NCBI
31	Miyazaki H, Patel V, Wang H, Edmunds RK, Gutkind JS and Yeudall WA: Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res. 66:4279–4284. 2006. View Article : Google Scholar : PubMed/NCBI
32	Richards BL, Eisma RJ, Spiro JD, Lindquist RL and Kreutzer DL: Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg. 174:507–512. 1997. View Article : Google Scholar : PubMed/NCBI
33	Kakinuma T and Hwang ST: Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol. 79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
34	Ruffini PA, Morandi P, Cabioglu N, Altundag K and Cristofanilli M: Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer. 109:2392–2404. 2007. View Article : Google Scholar : PubMed/NCBI
35	Balakin KV, Ivanenkov YA, Tkachenko SE, Kiselyov AS and Ivachtchenko AV: Regulators of chemokine receptor activity as promising anticancer therapeutics. Curr Cancer Drug Targets. 8:299–340. 2008. View Article : Google Scholar : PubMed/NCBI
36	Koizumi K, Hojo S, Akashi T, Yasumoto K and Saiki I: Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci. 98:1652–1658. 2007. View Article : Google Scholar : PubMed/NCBI
37	Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E and Richmond A: PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry. 41:7100–7107. 2002. View Article : Google Scholar : PubMed/NCBI
38	Schraufstatter IU, Chung J and Burger M: IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol. 280:L1094–L1103. 2001.PubMed/NCBI
39	Venkatakrishnan G, Salgia R and Groopman JE: Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem. 275:6868–6875. 2000. View Article : Google Scholar
40	Bonacchi A, Romagnani P, Romanelli RG, et al: Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem. 276:9945–9954. 2001. View Article : Google Scholar : PubMed/NCBI
41	Chandrasekar B, Melby PC, Sarau HM, et al: Chemokinecytokine cross-talk. The ELR⁺ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem. 278:4675–4686. 2003.PubMed/NCBI
42	Chandrasekar B, Bysani S and Mummidi S: CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem. 279:3188–3196. 2004. View Article : Google Scholar : PubMed/NCBI
43	Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L and Inferrera C: Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol. 15:831–837. 2002. View Article : Google Scholar : PubMed/NCBI
44	Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A and Musiani P: The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood. 97:339–345. 2001.PubMed/NCBI
45	Welch DR, Schissel DJ, Howrey RP and Aeed PA: Tumor-elicited polymorphonuclear cells, in contrast to ‘normal’ circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci USA. 86:5859–5863. 1989.PubMed/NCBI
46	De Larco JE, Wuertz BR and Furcht LT: The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 10:4895–4900. 2004.PubMed/NCBI
47	Schmausser B, Josenhans C, Endrich S, et al: Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection? Infect Immun. 72:6773–6779. 2004. View Article : Google Scholar : PubMed/NCBI
48	Backhed F, Torstensson E, Seguin D, Richter-Dahlfors A and Rokbi B: Helicobacter pylori infection induces interleukin-8 receptor expression in the human gastric epithelium. Infect Immun. 71:3357–3360. 2003. View Article : Google Scholar
49	Gabellini C, Trisciuoglio D, Desideri M, et al: Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer. 45:2618–2627. 2009. View Article : Google Scholar : PubMed/NCBI
50	Charafe-Jauffret E, Ginestier C, Iovino F, et al: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69:1302–1313. 2009. View Article : Google Scholar : PubMed/NCBI
51	Folkman J: Angiogenesis and apoptosis. Semin Cancer Biol. 13:159–167. 2003. View Article : Google Scholar
52	White ES, Flaherty KR, Carskadon S, et al: Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res. 9:853–860. 2003.PubMed/NCBI